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ABSTRACT 
Introduction: Lateral epicondylalgia (LE) is diagnosed clinically as pain over the lateral 
elbow that is provoked by gripping. Usually, LE responds well to conservative intervention, 
however those who fail such treatment require further evaluation, including musculoskeletal 
ultrasound. Previous studies of musculoskeletal ultrasound have methodological flaws, such 
as, lack of assessor blinding and failure to control for participant age, sex and arm dominance. 
The purpose of this study was to assess the diagnostic utility of blinded ultrasound imaging in 
people with clinically diagnosed LE compared to a control group matched for age, sex and 
arm dominance. 
Methods: Participants (30 with LE and 30 controls) underwent clinical examination as the 
criterion standard test. Unilateral LE was defined as pain over the lateral epicondyle, which 
was provoked by palpation, resisted wrist and finger extension and gripping. Controls without 
symptoms were matched for age, sex and arm dominance. Ultrasound investigations were 
performed by two sonographers using a standardised protocol. Greyscale images were 
assessed for signs of tendon pathology and rated on a four-point ordinal scale. Power Doppler 
was used to assess neovascularity and rated on a five-point ordinal scale.  
Results: The combination of greyscale and power Doppler imaging revealed an overall 
sensitivity of 90%, and specificity of 47%. The positive and negative likelihood ratios for 
combined greyscale and power Doppler imaging were 1.69 and 0.21, respectively. 
Conclusion: Although ultrasound imaging helps confirm the absence of LE, when findings 
are negative for tendinopathic changes, the high prevalence of tendinopathic changes in 
painfree controls challenges the specificity of the measure. The validity of ultrasound 
imaging to confirm tendon pathology in clinically diagnosed lateral epicondylalgia requires 
further study, with strong methodology. 
Keywords: tennis elbow; sensitivity; specificity, diagnostic accuracy, musculoskeletal 
ultrasound 
 
INTRODUCTION 
Lateral epicondylalgia (LE) commonly presents to primary care clinicians with an annual 
incidence of four to seven cases per 1000 patients in general practice(20) and between 1 to 4% 
prevalence in the general population(39, 43). This condition is thought to be an overuse 
syndrome of the common extensor tendon(33), resulting in pain and functional disability 
during gripping and manipulation of the hand(6). Those at a greater risk of developing LE 
include tennis players(18) and people who are required to use a combination of force, 
repetition and suboptimal wrist postures in their occupations(19, 39, 42). 
In both research and clinical practice LE is typically diagnosed using clinical criteria. These 
include aspects of patient history and provocation tests designed to reproduce pain over the 
lateral elbow (e.g. palpation, resisted wrist and finger extension, and gripping tasks(23)), 
without the requirement to include diagnostic imaging(26). Imaging techniques including 
muscluloskeletal ultrasound (MSUS) and magnetic resonance imaging (MRI) have been 
suggested for further investigation of patients with suspected LE who require further 
evaluation in preoperative planning or due to failure in conservative treatment(31, 44). MSUS 
is increasingly used as a selection criterion in clinical trials for lower limb tendinopathies 
such as Achilles and patellar tendons(9, 17, 30, 45), though this has not transferred to 
standard clinical practice. 
Tendon changes observed with greyscale MSUS of the common extensor tendon of people 
with LE include: tendon thickening, changes in tendon fibrillar patterns, focal areas of tendon 
hypoechogenicity, tendon calcification, and/or bone spurs and irregularities(4, 27, 31). Power 
Doppler MSUS identifies neovascularisation and this has been suggested as an element of the 
pathophysiological process of tendinopathy, and a potential contributor to the pain 
experience(24, 46). Previous reports using a combination of greyscale and power Doppler 
MSUS to diagnose LE demonstrate a large variation in the sensitivity and specificity ranging 
from 72 to 100% and 36 to 100%, respectively(10, 12, 26, 27, 34). Most of these studies have 
failed to include an age matched control group and most have not blinded the sonographer to 
the patient’s presentation. This latter issue may bias the selection of images to send for 
interpretation. The aim of this study was to determine the diagnostic accuracy of MSUS for 
confirmation of the clinical diagnosis of LE, with control of potential sources of bias, such as 
blinding the sonographer to the clinical diagnosis of each participant, and inclusion of a 
control group matched for age, sex and arm dominance. 
 
MATERIALS AND METHODS 
 
Participants 
Participants between 18 and 70 years of age, with unilateral LE symptoms were recruited via 
media advertising between January and July 2013. Inclusion criteria were the presence of 
pain over the lateral humeral epicondyle for greater than 6 weeks that was provoked by 
palpation over the lateral epicondyle, resisted wrist and middle finger extension, and gripping 
activities. Participants were excluded if they had neurological or systemic disease, limitations 
with passive movement of the forearm, indication of cervical radiculopathy or peripheral 
nerve involvement through neurodynamic tests, bilateral elbow symptoms, previous 
physiotherapy treatment or cortisone steroid injections, and neck or arm pain (other than LE), 
which had prevented participation in work or recreational activities, or required consultation 
of a health care practitioner in the past 6 months.  
Thirty healthy controls, matched for age, sex and arm dominance were recruited 
simultaneously, via media advertising. Inclusion criteria included no history or current signs 
and symptoms of lateral elbow pain, full pain-free range of motion, no pain with gripping or 
resisted wrist extension and no neck or arm pain, which had prevented participation in work 
or recreational activities, or required consultation of a health care practitioner in the past 6 
months. The Institutional Medical Research Ethics Committee approved the study and written 
informed consent was obtained from each participant prior to participation. 
 
Criterion standard examination 
The criterion standard was diagnosis made by clinical identification of LE(3), based on 
assessment by a registered physiotherapist. Both arms of each participant were assessed using 
the above inclusion/exclusion criteria. Each elbow was classified as either affected or 
unaffected. Clinical identification of LE was used as the criterion standard because: it is 
currently the gold standard for diagnosis of LE; is relatively simple and easy to administer(6); 
and is the accepted method for diagnosis in most published high quality randomised clinical 
trials(1, 8, 40) and observational studies(2, 13, 35). After completion of the clinical 
examination (criterion standard test) participants were given a referral for the MSUS 
assessment. 
 
Description of LE group  
To describe the LE group, we took the clinical measures of patient-rated tennis elbow 
evaluation (PRTEE) questionnaire, grip strength dynamometry, and visual analogue scales 
(VAS) for pain intensity. The validated PRTEE, which is specific to LE, includes 15 
questions measuring pain severity and functional disability, with an overall score from 0 – 
100 (higher scores imply worse pain and disability)(38). A 10-cm VAS was used (0 = “no 
pain” and 10 = “worst pain imaginable”) to assess current resting pain intensity and worst 
pain intensity over the preceding week. Pain-free grip force of the affected side of LE 
participants and the matched arm of controls was measured with an electronic grip 
dynamometer (MIE Medical Research Ltd., Leeds, UK). .During grip strength measurement 
the participant was supine with elbow extended beside their body and forearm pronated so 
that the palm was facing down(29). 
 
Ultrasound imaging and interpretation 
MSUS examinations were performed at CitiScan Radiology in Brisbane, Australia. 
Participants were examined bilaterally by one of two qualified musculoskeletal sonographers 
each with over 9 years’ experience. Sonographers were blinded to the results of all clinical 
examinations (criterion standard test) and group allocation. Ultrasound examination was 
performed using a Philips LU22 ultrasound with a high frequency linear area transducer 
(frequency range: 17-5MHz). The common extensor tendon was examined using a 
standardised protocol of still images involving longitudinal and transverse views.  
The standardised protocol involved assessment of greyscale images followed by power 
Doppler on the right elbow and then the left. Participants were seated with their arm 
supported on an examination table having 70° of elbow flexion and a neutral wrist (thumb 
pointing up). The greyscale imaging was used to assess tendon thickening, hypoechoic area/s, 
fibrillar disruption, and calcification, using a previously established scoring system(36). The 
sonographer assigned an ordinal value to each greyscale feature using a four-point 
abnormality scale with the following definitions: 0 = normal, 1 = only just apparent, 2 = 
visible in less than half the tendon, and 3 = visible in more than half the tendon. This system 
allows for an individual score of the four greyscale features as well as an aggregate 
abnormality rating by summing the scores together giving a possible maximum score of 12 
points.  
Power Doppler imaging was used to identify intra-tendon neovascularity. The specifications 
for power Doppler were a pulse repetition frequency of 500 Hz, wall filter of 40 Hz and pre-
set colour gain of 80%. Sonographers applied the transducer with light pressure to minimise 
potential for blood vessel constriction. As it has been suggested that more “levels” of 
abnormality can be assessed with power Doppler imaging(36), the sonographer rated 
neovascularisation on a five-point ordinal scale with the following definitions: 0 = no signal, 
1 = single small signal, 2 = several signals visible in less than 33% of the tendon, 3 = multiple 
signals in 33% – 66% of the tendon, and 4 = multiple signals in more than 67% of the tendon. 
To evaluate inter-tester reliability, both sonographers scored nine participants independently 
following the standardised protocol. 
 
Statistical analysis 
 
Although both clinical examination and MSUS were completed bilaterally for all participants, 
only the affected elbows of the LE group (n = 30) and the matched elbows of the controls (n 
= 30) were included in the analysis. This analysis was selected because of recent evidence 
from a systematic review with meta-analysis demonstrating motor system changes in the 
uninjured side of people with LE (21) and it was considered that this may bias the results. A 
series of two-by-two contingency tables were assembled to cross tabulate the results of the 
criterion standard test (affected or unaffected) and diagnostic ultrasound (positive or 
negative). Separate contingency tables were constructed for each category of tendon change 
interpreted from the greyscale image (thickening, hypoechoic area, fibrillar disruption, and 
calcification), neovascularisation score, total greyscale score ≥1, and sum of the total 
greyscale score and neovascularisation score. Contingency tables were then analysed to 
calculate point estimates of accuracy (sensitivity, specificity, positive and negative predictive 
values, and positive and negative likelihood ratios) and the respective 95% confidence 
intervals using MedCalc statistical software (MedCalc Software, Ostend, Belgium).  
Inter-tester reliability of the MSUS examination was assessed using SPSS V21 software 
(SPSS Inc, Chicago, IL, USA). Kappa statistics were used to report the inter-tester reliability 
between the two sonographers. Interpretation of inter-tester reliability was interpreted as poor 
(<0.00), slight (0.00–0.2), fair (0.21–0.4), moderate (0.41–0.6), substantial (0.61–0.8), or 
almost perfect (0.81–1.0) based on established criteria(25). Participant characteristics were 
assessed between LE and controls using Student’s t-tests.  
 
RESULTS 
 
Participants 
 
The recruitment and inclusion of participants within the study are detailed in Figure 1. 
Participant characteristics and demongraphics are presented in Table 1. As expected, the LE 
group demonstrated significantly less grip force during their painfree grip, compared to the 
controls maximum grip (p < 0.001).  
 
Inter-tester reliability  
 
Inter-tester reliability demonstrated moderate to almost perfect agreement for the scoring of 
greyscale (total and individual features) and neovascularity using diagnostic ultrasound 
(Table 2). Agreement was lowest for calcification (ĸ = 0.44) and total greyscale score (ĸ = 
0.49) but was still rated moderate. Neovascularity demonstrated highest agreement (ĸ = 0.86) 
and was rated as almost perfect. 
 
 
Diagnostic accuracy  
 
There were no adverse effects with respect to the clinical examination or diagnostic 
ultrasound. The criterion standard test and ultrasound examination were conducted on 
average one week apart for all participants (7.5 days, range 0 to 29). Table 3 displays the raw 
data from contingency tables, and the estimates of diagnostic utility and their 95% confidence 
intervals.  
Blinded diagnostic ultrasound identified 90% of the LE participants and 53% of the controls 
as having tendinopathic changes. Total greyscale score ≥1 and greyscale in combination with 
power Doppler ≥1 demonstrated a high sensitivity (87 to 90%) and low specificity (47 to 
50%). Both total greyscale score and greyscale in combination with power Doppler 
demonstrated a high negative predictive value (79-82%). These indices of accuracy were 
reflected with moderate negative likelihood ratios for total greyscale score ≥1 (0.27) and 
greyscale in combination with power Doppler (0.21). 
With the exception of specificity for fibrillar disruption and calcification, which was 100% 
and 83% respectively, the estimates for diagnostic accuracy of separate greyscale measures 
(thickening, hypoechoic area, fibrillar disruption, and calcification) were poor. Fibrillar 
disruption demonstrated a 100% positive predictive value and an extremely substantial 
positive likelihood ratio (infinity). Greyscale changes demonstrated a higher specificity (60 to 
100%) and lower sensitivity (7 to 70%) for individual categories, however when combined 
they resulted in the opposite effect (total greyscale score ≥1; sensitivity 87%, specificity 
50%). Neovascularisation demonstrated moderate measures of diagnostic utility (63 to 77%). 
 
 
DISCUSSION 
 
The aim of this study was to evaluate the diagnostic utility of blinded MSUS in a group of 
individuals who had been clinically diagnosed with LE compared to controls matched for age, 
sex and arm dominance. Overall our data demonstrate that greyscale MSUS in combination 
with power Doppler MSUS has the highest sensitivity (90%), whereas the finding of fibrillar 
disruption has the highest specificity (100%) for diagnosis of LE. When no abnormalities 
were observed using greyscale and power Doppler MSUS the probability of having the 
disorder drops to 0.28% from a prevalence of 1.3% in the general population(39). When 
considered alone, greyscale MSUS demonstrates a high sensitivity (87%) but a low 
specificity (50%), which suggests the technique performs well to confirm the clinical 
presentation but is inadequate to rule out the condition. Power Doppler MSUS appears to 
have moderate diagnostic utility (63 to 77%), however a negative result for power Doppler 
MSUS can help to exclude the likelihood of LE (post-test probability of 0.63% from 1.3% 
prevalence in the general population). Although most individual greyscale features 
demonstrate poor to moderate results for diagnostic utility (7 to 83%), disruption of the fibrils 
within the common extensor tendon reflects a 100% probability of having LE. 
Previous studies have reported findings for power Doppler and greyscale MSUS, 
separately(10, 26, 27) and in combination(12, 34). Our results for the accuracy of power 
Doppler MSUS to detect neovascularisation (Table 3) are aligned with previous reports for 
sensitivity (57 to 81%) but are noticeably lower than previously reported values for 
specificity (98 to 100%)(12, 34). However, estimates of specificity from the two previous 
studies may have been inflated by the failure to blind the sonographer, which may cause bias 
in selecting images and interpretation. The accuracy of greyscale MSUS to detect 
abnormalities in the current study (sensitivity 87%, specificity 50%) is comparable to 
previously reported sensitivities (72 to 100%) and specificities (36 to 100%)(10, 12, 26, 27, 
34). When compared with the one other study in which the sonographer was blinded(10), our 
study demonstrated a similar sensitivity (95%) but did not support the findings of specificity 
(98%). The large number of healthy participants with MSUS changes consistent with LE 
appears to explain the low specificity identified in the present study. 
Paragraph Number 20 Sixteen (53%) of the 30 elbows considered to be unaffected by LE 
were identified to have abnormalities based on greyscale and/or power Doppler MSUS 
assessment despite the absence of symptoms during the clinical examination. This finding is 
consistent with current literature, which suggests a high incidence of tendinopathic changes 
in asymptomatic individuals(5, 14, 22, 41). Recent studies imply that tendinopathic 
abnormalities in healthy controls are a feature of increasing age, especially for the dominant 
arm(22, 41). As LE predominately affects the dominant arm(20), 77% of the elbows 
investigated in the control group were from the dominant arm and this may contribute to the 
high prevalence of abnormalities. It would be interesting to follow individuals with these 
changes in a longitudinal manner to determine whether asymptomatic tendinopathy develops 
into symptomatic tendinopathy. Twenty-seven (90%) of the 30 elbows that were symptomatic 
for LE had abnormalities detected on greyscale and/or power Doppler MSUS. Only three 
affected elbows were free from any identified changes. Inspection of the demographic data 
and results of the criterion standard examination for these three participants against the mean 
of the LE group revealed no obvious reason for difference in presentation. Similar 
observations have been made for other tendinopathies. A study of clinically diagnosed 
symptomatic Achilles and patella tendinopathy using MSUS found no identifiable tendon 
changes in two thirds of participants(15). 
MSUS depends on the skill of the operator(4, 11, 27) and potential sources of variability 
include both the collection and interpretation of the images. Inter-tester reliability in previous 
studies has ranged from extremely poor to perfect agreement depending on the anatomical 
feature or MSUS characteristic that is measured(11, 36). For example one study demonstrated 
perfect agreement (κ = 1.0) for identification of bony irregularities of the lateral epicondyle 
but no agreement (κ = 0) for the margins of the common extensor tendon(11). The same 
study found moderate agreement for calcification (κ = 0.53) (in line with the findings of our 
study (κ = 0.44)), but only moderate agreement for neovascularity (κ = 0.60), which is 
substantially lower than our findings (κ = 0.86). The low score in inter-tester reliability for 
calcification may be explained by differences in interpretation of how this is defined. Our 
study demonstrated higher agreement for fibrillar disruption (κ = 0.58), and tendon 
thickening (κ = 0.68), but lower agreement in total greyscale score (κ = 0.49) than a recent 
study, from which our scoring sheet was customised(36). 
In drawing inferences from this data the reader should be cognisant of the characteristics of 
the LE group being studied. The PRTEE score (36.2 ±14.2), pain-free grip force (106.0 N 
±59.3), and worst pain in the previous week (VAS 6.6 ±2.2) are consistent with participants 
recruited for clinical studies(1, 7, 8, 40). The disproportionately high specificity for fibrillar 
disruption may be linked to the pathophysiological mechanisms associated with tedinosis, 
including the increase in tenocyte numbers and disruption of the collagen fibres(16, 32, 37). 
A limitation of the present study was the time between the clinical examination (criterion 
standard test) and the MSUS assessment. Eighteen (30%) participants were able to attend the 
MSUS assessment within 48 hours of the clinical examination, 22 (37%) attended within one 
week, 12 (20%) attended within two weeks, 3 (5%) attended within three weeks and 5 (8%) 
took more than three weeks to attend. It is important to consider the findings of this study in 
light of the case-control study design, which compared participants who definitely had LE 
against participants who did not. This study design has been suggested to estimate diagnostic 
accuracy up to four times higher than that of other study designs(28). An alternative study 
design is a consecutive cohort, which measures the accuracy of MSUS in a homogenous 
group of participants presenting with a similar clinical presentation, which would be likely to 
yield lower values than those reported here.  
In conclusion, the present study shows that blinded greyscale MSUS alone or in combination 
with power Doppler imaging is accurate for confirmation of the clinical diagnosis of LE, but 
with varying levels of sensitivity and specificity based on the individual parameters included. 
The high sensitivity implies that individuals who present with lateral elbow pain but no 
observable tendon changes on MSUS examination should be investigated for an alternative 
cause of pain. Research is required to determine the longitudinal outcome of asymptomatic 
tendinopathy.  
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Figure 1. Participant flow chart 
 
 
Table 1 Participant characteristics and demographics (mean (SD) or n(%)) 
 
LE  
(n = 30) 
Control  
(n = 30) 
Sex: Male 16 (53%) 16 (53%) 
Age in years (range) 49.6 (31 to 65)  50.6 (34 to 68) 
BMI  27.2 (5.17) 25.9 (3.84) 
Pain Free Grip strength in Newtons 106.0 (59.3)* 308.3 (87.4) 
Right arm dominant  29 29 
Dominant arm affected (%) 23 (77%) n/a 
Duration of symptoms in weeks 
(range) 
19.9 (8 to 52) n/a 
PRTEE out of 100 36.2 (14.2) n/a 
Pain severity out of 10 6.6 (2.2) n/a 
* indicates significance (p < 0.001), LE – lateral epicondylalgia group, BMI – 
body mass index,, PRTEE – patient rated tennis elbow evaluation, n/a – not 
applicable 
 
  
Table 2 Inter-tester reliability between sonographers (n = 9) 
 Kappa ICC 
Tendon thickening 0.68 0.92 (0.67 to 0.98) 
Hypoechoic area 0.80 0.81 (0.39 to 0.95) 
Fibrillar Disruption 0.58 0.73 (0.37 to 0.96 
Calcification  0.44 0.64 (0.01 to 0.91) 
Total Greyscale score ≥1  0.49 0.94 (0.75 to 0.99) 
Neovascularity 0.86 0.98 (0.93 to 1.00) 
95% confidence intervals are presented in parenthesis  
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Table 3 Reported findings from ultrasound examination with and without power Doppler compared to clinical examination 
Number of affected and unaffected elbows 
(from contingency tables) 
Diagnostic utility, expressed as percentages (95% confidence intervals) 
 TP  FN  TN  FP  Sensitivity Specificity PPV NPV  Positive LR  Negative LR 
Tendon 
thickening 
21  9  20  10  70 (52 to 83) 67 (49 to 81) 68 (49 to 83) 69 (49 to 84) 2.10 (1.20 to 3.67) 0.45 (0.25 to 0.82) 
Hypoechoic area 16  14  18  12 53 (36 to 70) 60 (42 to 75) 47 (30 to 65) 46 (27 to 66) 1.33 (0.77 to 2.31) 0.78 (0.48 to 1.26) 
Fibrillar 
Disruption 
13 17 30 0  43 (27 to 61) 100 (89 to 100) 100 (72 to 100) 64 (48 to 77) Infinity 0.57 (0.41 to 0.78) 
Calcification  2 28 25 5 7 (2 to 21) 83 (66 to 93) 29 (5 to 70) 47 (34 to 61) 0.40 (0.08 to 1.90) 1.12 (0.93 to 1.35) 
Total Greyscale 
score ≥1  
26 4 15 15 87 (70 to 95) 50 (33 to 67) 63 (47 to 77) 79 (54 to 93) 1.73 (1.18 to 2.55) 0.27 (0.10 to 0.71) 
Neovascularity 19 11 23 7 63 (45 to 78) 77 (59 to 88) 73 (52 to 88) 68 (49 to 82) 2.71 (1.34 to 5.49) 0.48 (0.29 to 0.80) 
Greyscale &/or 
neovascularity 
27 3 14 16  90 (74 to 97) 47 (30 to 64) 63 (47 to 77) 82 (56 to 95) 1.69 (1.18 to 2.41) 0.21 (0.07 to 0.67) 
Note: TP – true positive, FN – false negative, TN – true negative, FP – false positive, PPV – positive predictive value, NPV – negative 
predictable value, LR – likelihood ratio 
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